Litigation Details for AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2021)
✉ Email this page to a colleague
AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2021)
Docket | ⤷ Sign Up | Date Filed | 2021-06-18 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 10,300,065; 8,425,934 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Alembic Pharmaceuticals Ltd.
Details for AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-06-18 | 3 | ANDA Form | Date of Expiration of Patent: 4/17/2030 (8,425,934) and 1/27/2036 (10,300,065).Thirty Month Stay Deadline… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 18 June 2021 1:21-cv-00875 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-06-18 | 4 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,425,934 ;10,300,065. (mal) (Entered… 18 June 2021 1:21-cv-00875 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |